These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1429 related articles for article (PubMed ID: 8630312)
41. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone. Akerlund M; Almström E; Högstedt S; Nabrink M Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352 [TBL] [Abstract][Full Text] [Related]
42. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives. Norris LA; Bonnar J Thromb Haemost; 1994 Dec; 72(6):926-30. PubMed ID: 7740465 [TBL] [Abstract][Full Text] [Related]
43. Sex hormone binding globulin, cortisol binding globulin, thyroxine binding globulin, ceruloplasmin: changes in treatment with two oral contraceptives low in oestrogen. Sobbrio GA; Granata A; Granese D; D'Arrigo F; Panacea A; Nicita R; Pullè C; Trimarchi F Clin Exp Obstet Gynecol; 1991; 18(1):43-5. PubMed ID: 1829029 [TBL] [Abstract][Full Text] [Related]
44. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives. Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781 [TBL] [Abstract][Full Text] [Related]
45. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629 [TBL] [Abstract][Full Text] [Related]
52. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives. Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462 [TBL] [Abstract][Full Text] [Related]
53. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives. Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059 [TBL] [Abstract][Full Text] [Related]
54. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750 [TBL] [Abstract][Full Text] [Related]
55. Phase III clinical trial with a new oral contraceptive containing 150 micrograms desogestrel and 20 micrograms ethinylestradiol. Lammers P; op ten Berg M Acta Obstet Gynecol Scand; 1991; 70(6):497-500. PubMed ID: 1837199 [TBL] [Abstract][Full Text] [Related]
56. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol. Bonnar J; Daly L; Carroll E Int J Fertil; 1987; 32 Suppl():21-8. PubMed ID: 2906344 [TBL] [Abstract][Full Text] [Related]
57. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel. Hammond GL; Langley MS; Robinson PA; Nummi S; Lund L Fertil Steril; 1984 Jul; 42(1):44-51. PubMed ID: 6233179 [TBL] [Abstract][Full Text] [Related]
58. Desogestrel versus gestodene in oral contraceptives: influence on the clinical and histomorphological features of benign breast disease. Di Lieto A; De Rosa G; Albano G; Pagnano AM; Campanile M; Terracciano L; Pontillo M; Cimmino E; Covelli A; Paladini A Eur J Obstet Gynecol Reprod Biol; 1994 May; 55(1):71-83. PubMed ID: 7958144 [TBL] [Abstract][Full Text] [Related]
59. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404 [TBL] [Abstract][Full Text] [Related]
60. A comparison of the effects of two triphasic oral contraceptives on haemostasis. Cohen H; Mackie IJ; Walshe K; Gillmer MD; Machin SJ Br J Haematol; 1988 Jun; 69(2):259-63. PubMed ID: 3390394 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]